Product Wiki · Recalls · EU Safety Gate (RAPEX)

Loaferit Uno2970 — recall SR/01088/26

EU Safety Gate (RAPEX) · Finland · 2026-04-17 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/01088/26
Date of alert
2026-04-17
Country / jurisdiction
Finland
Risk level
Serious risk
Risk type
Chemical
Brand
Create
Product category
Clothing, textiles and fashion items
Product type
Leather shoes
Barcode (EAN/GTIN)
2001005329583
🔴 Serious hazard — Reported risk: Tuotteen nahka sisältää kromi VI:ta (mitattu arvo jopa 14,1 mg/kg). Kromi (VI) on herkistävä, voi laukaista allergisia reaktioita ja voi aiheuttaa syöpää. Tuote ei täytä REACH-asetuksen vaatimuksia.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Importer
Category of measure
Destruction of the product
Date of entry into force
27/03/2026
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Loaferit Uno2970

Risk Description (original English): The leather in the product contains chromium VI (measured value up to 14.1 mg/kg). Chromium (VI) is sensitising, can trigger allergic reactions and can cause cancer.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10098559

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.